$ONTX Onconova Therapeutics, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Onconova Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Onconova Therapeutics, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Onconova Therapeutics, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| 683 Capital Management, LLC | 10% Owner | 848,151 | 2,273,045 | shares bought: 12,238,235 / shares sold: -506,877 | STRONG BUY | Sep 20 2019 | |
| Altland James | SVP, Finance & Corp. Develop. | 10,000 | 26,800 | Dec 24 2013 | |||
| ARMISTICE CAPITAL, LLC | 10% Owner | 816,702 | 2,188,761 | shares bought: 0 / shares sold: -10,249 | STRONG SELL | Sep 25 2019 | |
| BANSAL AJAY | Chief Financial Officer | 0 | 0 | Jan 28 2016 | |||
| BANSAL AJAY | Chief Financial Officer | 43,846 | 117,507 | Dec 22 2014 | |||
| Baxter Healthcare SA | 10% Owner | 0 | 0 | May 08 2015 | |||
| Bienen Henry S | Director | 22,724 | 60,900 | shares bought: 21,230 / shares sold: 0 | STRONG BUY | May 31 2018 | |
| Bienen Henry S | Director | 14,935 | 40,026 | Aug 05 2014 | |||
| Fruchtman Steven M | President, Chief Executive Off | 236,226 | 633,086 | shares bought: 391,176 / shares sold: 0 | STRONG BUY | Feb 19 2021 | 16 months ago |
| GROOPMAN JEROME | Director | 10,001 | 26,803 | shares bought: 10,010 / shares sold: 0 | STRONG BUY | Jul 10 2020 | 24 months ago |
| GROOPMAN JEROME | Director | 0 | 0 | Aug 05 2014 | |||
| Guerin Mark Patrick | Chief Financial Officer | 145,213 | 389,171 | shares bought: 149,964 / shares sold: 0 | STRONG BUY | Feb 19 2021 | 16 months ago |
| Hoffman Michael B | Director | 21,919 | 58,743 | shares bought: 2,740,610 / shares sold: -284,367 | STRONG BUY | Aug 31 2020 | 22 months ago |
| Hoffman Michael B | Director | 0 | 0 | Jul 29 2013 | |||
| Kumar Ramesh | Chief Executive Officer | 102,227 | 273,968 | shares bought: 74,575 / shares sold: 0 | STRONG BUY | Jul 30 2018 | |
| Maniar Manoj | SVP - Product Development | 50 | 134 | shares bought: 50 / shares sold: 0 | BUY | Jul 10 2020 | 24 months ago |
| MARINO JAMES J | Director | 230,716 | 618,319 | shares bought: 366,255 / shares sold: 0 | STRONG BUY | Feb 17 2021 | 17 months ago |
| MCKEARN THOMAS J | President, R&D | 0 | 0 | Jan 28 2016 | |||
| MCKEARN THOMAS J | President, R&D | 3,333 | 8,932 | Dec 22 2014 | |||
| MEHTA VIREN | Director | 250,857 | 672,297 | shares bought: 250,000 / shares sold: 0 | BUY | Jul 10 2020 | 24 months ago |
| MEHTA VIREN | Director | 1,733 | 4,644 | Aug 05 2014 | |||
| Michael & Jane Hoffman 2013 Descendants | 10% Owner | 4,518,275 | 12,108,977 | Feb 24 2014 | |||
| OLER ABRAHAM N. | SVP Corp Dev & Gen Counsel | 152,000 | 407,360 | shares bought: 227,000 / shares sold: 0 | STRONG BUY | Feb 19 2021 | 16 months ago |
| Reddy E Premkumar | Director | 16,683 | 44,710 | shares bought: 1,034,398 / shares sold: -527,863 | STRONG BUY | Aug 31 2020 | 22 months ago |
| Shoemaker Mary Teresa | Director | 50,735 | 135,970 | shares bought: 63,735 / shares sold: 0 | STRONG BUY | Feb 17 2021 | 17 months ago |
| STOVER JACK E | Director | 47,110 | 126,255 | shares bought: 47,100 / shares sold: 0 | BUY | Jul 10 2020 | 24 months ago |
| TYNDALL CAPITAL PARTNERS L P | 10% Owner | 616,389 | 1,651,923 | shares bought: 11,723,248 / shares sold: -199,883 | STRONG BUY | Sep 26 2019 | |
| VANLENT ANNE | Director | 0 | 0 | Jun 17 2015 | |||
| VANLENT ANNE | Director | 0 | 0 | Aug 05 2014 | |||
| VANLENT ANNE | Director | 0 | 0 | Jul 29 2013 | |||
| Woodman Richard Charles | Chief Medical Officer | 0 | 0 | Jul 10 2020 | 24 months ago |